BHVN logo

BHVN Long Term Liabilities

Annual Total Long Term Liabilities

$37.45 M
+$7.63 M+25.60%

December 31, 2024


Summary


Performance

BHVN Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBHVNbalance sheetmetrics:

Quarterly Long Term Liabilities

$37.45 M
-$4.78 M-11.32%

December 31, 2024


Summary


Performance

BHVN Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBHVNbalance sheetmetrics:

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

BHVN Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+25.6%+25.6%
3 y3 years+589.0%+13.5%
5 y5 years-86.9%+13.5%

BHVN Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+589.0%-12.3%+435.3%
5 y5-year-86.9%+673.5%-95.0%+589.0%
alltimeall time-86.9%+7766.6%-95.0%+2475.3%

Biohaven Pharmaceutical Holding Long Term Liabilities History

DateAnnualQuarterly
Dec 2024
$37.45 M(+25.6%)
$37.45 M(-11.3%)
Sep 2024
-
$42.22 M(-1.1%)
Jun 2024
-
$42.69 M(+40.0%)
Mar 2024
-
$30.50 M(+2.3%)
Dec 2023
$29.81 M(-9.6%)
$29.81 M(-2.4%)
Sep 2023
-
$30.55 M(-3.4%)
Jun 2023
-
$31.63 M(-1.9%)
Mar 2023
-
$32.26 M(-2.2%)
Dec 2022
$32.99 M(+507.0%)
$32.99 M(+371.6%)
Sep 2022
-
$7.00 M(-5.1%)
Jun 2022
-
$7.37 M(+35.6%)
Dec 2021
$5.43 M(+12.3%)
-
Dec 2021
-
$5.43 M(-99.3%)
Dec 2020
$4.84 M(-98.3%)
-
Dec 2020
-
$741.56 M(+3.2%)
Sep 2020
-
$718.72 M(+145.0%)
Jun 2020
-
$293.30 M(+1.6%)
Mar 2020
-
$288.61 M
DateAnnualQuarterly
Dec 2019
$285.51 M(+138.8%)
-
Dec 2019
-
$285.51 M(+4.6%)
Sep 2019
-
$272.90 M(+5.2%)
Jun 2019
-
$259.50 M(+108.6%)
Mar 2019
-
$124.38 M(+4.0%)
Dec 2018
$119.56 M(+2078.5%)
-
Dec 2018
-
$119.56 M(+4.9%)
Sep 2018
-
$114.01 M(+5.9%)
Jun 2018
-
$107.70 M(+7307.5%)
Mar 2018
-
$1.45 M(-73.5%)
Dec 2017
$5.49 M(-91.4%)
-
Dec 2017
-
$5.49 M(-13.8%)
Sep 2017
-
$6.36 M(+63.9%)
Jun 2017
-
$3.88 M(-96.1%)
Mar 2017
-
$98.29 M(+53.3%)
Dec 2016
$64.11 M(>+9900.0%)
-
Dec 2016
-
$64.11 M
Dec 2015
$476.00 K
-

FAQ

  • What is Biohaven Pharmaceutical Holding annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding annual total long term liabilities year-on-year change?
  • What is Biohaven Pharmaceutical Holding quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Biohaven Pharmaceutical Holding?
  • What is Biohaven Pharmaceutical Holding quarterly long term liabilities year-on-year change?

What is Biohaven Pharmaceutical Holding annual total long term liabilities?

The current annual total long term liabilities of BHVN is $37.45 M

What is the all time high annual total long term liabilities for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high annual total long term liabilities is $285.51 M

What is Biohaven Pharmaceutical Holding annual total long term liabilities year-on-year change?

Over the past year, BHVN annual total long term liabilities has changed by +$7.63 M (+25.60%)

What is Biohaven Pharmaceutical Holding quarterly total long term liabilities?

The current quarterly long term liabilities of BHVN is $37.45 M

What is the all time high quarterly long term liabilities for Biohaven Pharmaceutical Holding?

Biohaven Pharmaceutical Holding all-time high quarterly total long term liabilities is $741.56 M

What is Biohaven Pharmaceutical Holding quarterly long term liabilities year-on-year change?

Over the past year, BHVN quarterly total long term liabilities has changed by +$7.63 M (+25.60%)